Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Celularity's Other Operating Expenses rose 51.67% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.3 million, marking a year-over-year increase of 52889.87%. This contributed to the annual value of $16.5 million for FY2024, which is 8765.16% down from last year.
  • According to the latest figures from Q3 2025, Celularity's Other Operating Expenses is $4.3 million, which was up 51.67% from $5.6 million recorded in Q2 2025.
  • Celularity's 5-year Other Operating Expenses high stood at $87.1 million for Q3 2023, and its period low was -$45.7 million during Q3 2021.
  • Its 5-year average for Other Operating Expenses is $1.8 million, with a median of $4.3 million in 2024.
  • Data for Celularity's Other Operating Expenses shows a peak YoY increase of 918616.66% (in 2021) and a maximum YoY decrease of 93033.38% (in 2021) over the last 5 years.
  • Over the past 5 years, Celularity's Other Operating Expenses (Quarter) stood at -$18.1 million in 2021, then plummeted by 140.08% to -$43.4 million in 2022, then soared by 67.76% to -$14.0 million in 2023, then skyrocketed by 153.76% to $7.5 million in 2024, then plummeted by 43.13% to $4.3 million in 2025.
  • Its Other Operating Expenses was $4.3 million in Q3 2025, compared to $5.6 million in Q2 2025 and $3.9 million in Q1 2025.